Valuation: Sartorius Stedim Biotech

Market Cap 16.28B 18.53B 15.14B 13.89B 26.1B 1,785B 26.5B 180B 70.23B 877B 69.57B 68.07B 3,034B P/E 2026 *
42.9x
P/E 2027 * 32.2x
Enterprise Value 18.27B 20.8B 16.99B 15.59B 29.29B 2,003B 29.75B 202B 78.82B 985B 78.09B 76.4B 3,405B EV / Sales 2026 *
5.84x
EV / Sales 2027 * 5.18x
Free-Float
28.47%
Yield 2026 *
0.5%
Yield 2027 * 0.63%
1 day+2.01%
1 week-10.73%
Current month-7.87%
1 month+2.51%
3 months+5.95%
6 months-18.79%
Current year-20.33%
1 week 158.9
Extreme 158.9
187.4
1 month 158.9
Extreme 158.9
190.8
Current year 150
Extreme 150
224
1 year 150
Extreme 150
224
3 years 139.1
Extreme 139.1
287.8
5 years 139.1
Extreme 139.1
551
10 years 50.13
Extreme 50.13
551
Manager TitleAgeSince
Chief Executive Officer 51 2023-03-27
Chief Tech/Sci/R&D Officer 61 2011-09-07
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 65 2015-04-06
Director/Board Member 69 2015-04-06
Director/Board Member 69 2017-09-13
Date Insider Type Main position Quantity % Market Cap.
12/17/25 SellCompany 750,000 0.7706%
2/16/24 Buy

Chief Executive Officer

1,716,739 1.8624%
3/2/22 SellCompany 200,442 0.2174%
Change 5-day change 1-year change 3-year change Capi.($)
+2.01%-10.73%-3.21%-38.49% 18.14B
+2.29%+2.36%-17.97%-10.09% 175B
+1.46%+0.01%-9.87%-6.25% 105B
+1.58%+0.65%+6.69%+61.86% 59.35B
-1.13%-1.96%+32.11%+56.38% 50.71B
+2.22%-1.14%-14.85%-44.15% 42.15B
+2.98%-2.61% - - 31.82B
+1.50%-6.67%-17.52%-43.99% 27.2B
-7.67%-8.39%+17.59%-12.73% 25.11B
+1.63%-1.73%-5.80%-7.80% 20.53B
Average +0.66%-4.33%-1.43%-5.03% 55.55B
Weighted average by Cap. +1.23%-1.87%-5.73%-0.25%

Financials

2026 *2027 *
Net sales 3.13B 3.56B 2.91B 2.67B 5.02B 343B 5.1B 34.56B 13.5B 169B 13.38B 13.09B 583B 3.48B 3.96B 3.23B 2.97B 5.58B 381B 5.66B 38.41B 15.01B 188B 14.87B 14.55B 648B
Net income 367M 418M 342M 314M 589M 40.29B 598M 4.06B 1.59B 19.81B 1.57B 1.54B 68.48B 486M 553M 452M 414M 779M 53.24B 791M 5.36B 2.09B 26.17B 2.08B 2.03B 90.5B
Net Debt 1.99B 2.27B 1.85B 1.7B 3.19B 218B 3.24B 22B 8.59B 107B 8.51B 8.33B 371B 1.74B 1.98B 1.62B 1.49B 2.79B 191B 2.83B 19.22B 7.51B 93.81B 7.44B 7.28B 324B
Logo Sartorius Stedim Biotech
Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key production sites are located in Germany, France and Puerto Rico.
Employees
10,477
Date Price Change Volume
26-07-24 167.30 +2.01% 105,317
26-07-23 €164.00 -6.45% 215,014
26-07-22 €175.30 +5.22% 134,439
26-07-21 €166.60 -7.55% 213,161
26-07-20 €180.20 -2.96% 55,079
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
167.30EUR
Average target price
231.57EUR
Spread / Average Target
+38.42%

Quarterly revenue - Rate of surprise